Evaluation of a Direct Oral Penicillin Challenge in a Rural Community
Status:
Recruiting
Trial end date:
2024-12-15
Target enrollment:
Participant gender:
Summary
This study aims to evaluate the outcomes of a rural-DOC Pilot clinic which will be
established in the Huntsville site of Muskoka Algonquin Healthcare. Patients from the Muskoka
region who are confirmed to have a low-risk penicillin allergy are eligible for participation
in the DOC clinic. Following their experience with the DOC, participation in this study will
be voluntary and feedback will be requested from each participant, and local primary care
providers. The feedback will be used to assess the impact of the DOC clinic on participants
and the medical community over the 2 - year study. Feedback will also be collected to
investigate ongoing antimicrobial use for those participants who were successfully delabeled.
This will be accomplished by surveying participants at six and twelve months after their DOC.